758 related articles for article (PubMed ID: 25524718)
1. Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings.
Arentz S; Abbott JA; Smith CA; Bensoussan A
BMC Complement Altern Med; 2014 Dec; 14():511. PubMed ID: 25524718
[TBL] [Abstract][Full Text] [Related]
2. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
3. Combined Lifestyle and Herbal Medicine in Overweight Women with Polycystic Ovary Syndrome (PCOS): A Randomized Controlled Trial.
Arentz S; Smith CA; Abbott J; Fahey P; Cheema BS; Bensoussan A
Phytother Res; 2017 Sep; 31(9):1330-1340. PubMed ID: 28685911
[TBL] [Abstract][Full Text] [Related]
4. Ovarian surgery for symptom relief in women with polycystic ovary syndrome.
Lepine S; Jo J; Metwally M; Cheong YC
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD009526. PubMed ID: 29125183
[TBL] [Abstract][Full Text] [Related]
5. Standardised versus individualised multiherb Chinese herbal medicine for oligomenorrhoea and amenorrhoea in polycystic ovary syndrome: a randomised feasibility and pilot study in the UK.
Lai L; Flower A; Prescott P; Wing T; Moore M; Lewith G
BMJ Open; 2017 Feb; 7(2):e011709. PubMed ID: 28159846
[TBL] [Abstract][Full Text] [Related]
6. Nutritional supplements and herbal medicines for women with polycystic ovary syndrome; a systematic review and meta-analysis.
Arentz S; Smith CA; Abbott J; Bensoussan A
BMC Complement Altern Med; 2017 Nov; 17(1):500. PubMed ID: 29178904
[TBL] [Abstract][Full Text] [Related]
7. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
Morley LC; Tang T; Yasmin E; Norman RJ; Balen AH
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD003053. PubMed ID: 29183107
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive review of clinical studies with herbal medicine on polycystic ovary syndrome (PCOS).
Moini Jazani A; Nasimi Doost Azgomi H; Nasimi Doost Azgomi A; Nasimi Doost Azgomi R
Daru; 2019 Dec; 27(2):863-877. PubMed ID: 31741280
[TBL] [Abstract][Full Text] [Related]
9. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
10. Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association.
Morgante G; Cappelli V; Di Sabatino A; Massaro MG; De Leo V
Minerva Ginecol; 2015 Oct; 67(5):457-63. PubMed ID: 26491824
[TBL] [Abstract][Full Text] [Related]
11. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.
Genazzani AD; Lanzoni C; Ricchieri F; Baraldi E; Casarosa E; Jasonni VM
Gynecol Endocrinol; 2007 Mar; 23(3):146-52. PubMed ID: 17454168
[TBL] [Abstract][Full Text] [Related]
12. Correction of insulin resistance and hyperandrogenism in polycystic ovary syndrome by combined rosiglitazone and clomiphene citrate therapy.
Shobokshi A; Shaarawy M
J Soc Gynecol Investig; 2003 Feb; 10(2):99-104. PubMed ID: 12593999
[TBL] [Abstract][Full Text] [Related]
13. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
Karrer-Voegeli S; Rey F; Reymond MJ; Meuwly JY; Gaillard RC; Gomez F
Medicine (Baltimore); 2009 Jan; 88(1):32-45. PubMed ID: 19352298
[TBL] [Abstract][Full Text] [Related]
14. Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities.
Elkind-Hirsch KE
Treat Endocrinol; 2006; 5(3):171-87. PubMed ID: 16677059
[TBL] [Abstract][Full Text] [Related]
15. Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trial.
Jedel E; Labrie F; Odén A; Holm G; Nilsson L; Janson PO; Lind AK; Ohlsson C; Stener-Victorin E
Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E37-45. PubMed ID: 20943753
[TBL] [Abstract][Full Text] [Related]
16. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a Herbal Formulation Based on
Falahat F; Ayatiafin S; Jarahi L; Mokaberinejad R; Rakhshandeh H; Feyzabadi Z; Tavakkoli M
Curr Drug Discov Technol; 2020; 17(1):68-78. PubMed ID: 30370852
[TBL] [Abstract][Full Text] [Related]
18. Anti-Müllerian hormone: correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study.
Pinola P; Morin-Papunen LC; Bloigu A; Puukka K; Ruokonen A; Järvelin MR; Franks S; Tapanainen JS; Lashen H
Hum Reprod; 2014 Oct; 29(10):2317-25. PubMed ID: 25056088
[TBL] [Abstract][Full Text] [Related]
19. Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism.
Ezeh U; Ezeh C; Pisarska MD; Azziz R
Fertil Steril; 2021 Jun; 115(6):1557-1568. PubMed ID: 33602559
[TBL] [Abstract][Full Text] [Related]
20. Pre-polycystic ovary syndrome and polymenorrhoea as new facets of polycystic ovary syndrome (PCOS): Evidences from a single centre data set.
Ganie MA; Rashid A; Baba MS; Zargar MA; Wani IA; Nisar S; Wani IA; Douhath S; Sriwastawa M; Geer MI; Asrar MM; Kutum R; Hassan S; Khan S; Rafi W; Bhat DA; Showkat W; Sahar T; Choh NA; Khurshid R; Mudassar S; Shah ZA; Shabir I; Sofi SA; Gupta N; Hafeez I; Sreenivas V
Clin Endocrinol (Oxf); 2023 Dec; 99(6):566-578. PubMed ID: 37656656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
